Drawing for PRECISION PATHWAY

USPTO serial 98961415

PRECISION PATHWAY

Reviewed by CopyMark Law Group

Status 748
Filing date
Status date
Registration date
—
Examiner
CORWIN, CHARLOTTE K
Law office
TMO LAW OFFICE 119

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PRECISION PATHWAY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Devin Lee Looijen

101 S Ellsworth AveSTE 350San Mateo, CA 94401

Goods and services

ClassDescriptionStatusFirst use
042Consulting services in the field of genetic science; Providing medical testing services and information in the field of cancer research and disease classification; Health care computer network integration consulting in the field of information technology (IT), medical record integrations, and workflow integrationsACTIVESep 16, 2026
044Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Clinical medical consultation services; Consulting services in the field of medical care; Genetic testing for medical purposes; Genetic testing for cancer risk for medical purposes; Health care services, namely, genetic testing and diagnostics relating to precision medicine; Medical diagnostic testing, monitoring and reporting services; Medical laboratory analysis services relating to the treatment of persons; Medical screening services in the field of precision medicine and genetics services; Medical services; Medical services, namely, precision medicine and genetics services; Medical testing for diagnostic or treatment purposes; Medical testing services; Providing personalized healthcare and medical information in the nature of genetic testing results and analysis; Provision of health information; Consultancy services relating to health care; Managed health care servicesACTIVESep 16, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 16, 2026IUAFUSE AMENDMENT FILED—
Sep 16, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 11, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 16, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 19, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 19, 2026XAECEXAMINER'S AMENDMENT ENTERED—
May 19, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
May 19, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 6, 2026DOCKASSIGNED TO EXAMINER—
Sep 15, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 14, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 14, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Mar 14, 2025CNSLSUSPENSION LETTER WRITTEN—
Mar 13, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 13, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 10, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 10, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 10, 2025DOCKASSIGNED TO EXAMINER—
Jan 14, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 14, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance